Shares of Swiss Drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results. Go to CNBC
Der Beitrag Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs erschien zuerst auf TradingFaculty.This post first appeared on TRADINGFACULTY EDUCATIONAL TRADING RESOURCES, please read the originial post: here
